Company Focus. Polyplex (Thailand) Thailand. FV Bt3.04 SET: (Downgrade from Buy)

Similar documents
Thailand Banks. Thailand Industry Focus. Loan growth driven by demand for working capital. DBS Group Research. Equity 26 May 2015 SET : 1,508.

Oil & Gas Sector. Thailand Industry Focus

CSE Global. Singapore Company Focus

Thai Airways. Thailand Company Focus. Impressive 1Q10, as expected

Singapore Flash Note. StarHub (STH SP) : FULLY VALUED. Mobile, pay TV declines hit bottom line. DBS Group Research.

Polyplex (Thailand) Thailand Company Focus. Packing a big punch in 2011

Polyplex (Thailand) Public Limited Company

Flash Note. Singapore. Keppel Corporation (KEP SP) : HOLD. Signs agreement with Borr Drilling for Transocean units

Singapore Property. Singapore Industry Focus. A Quiet Start to DBS Group Research. Equity 16 Feb 2016 STI : 2,607.90

CSE Global. Singapore Company Focus

Ramayana Lestari (RALS IJ)

Flash Note. Bumi Armada (BAB MK) : BUY. 2Q16 in line: Recognized RM575m impairment. Malaysia Equity Research 29 Aug 2016

Hang Lung Properties. China / Hong Kong Company Guide

BHEL SELL RESULTS REVIEW 1QFY15 13 AUG CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

Amber Enterprises India Ltd

TCL Communication (LHS)

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Bangkok Bank. Thailand Company Guide. HOLD (downgrade) Last Traded Price ( 4 May 2017): Bt182 (SET : 1,573.05) Price Target 12-mth: Bt190 (4% upside)

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

GAIL India NEUTRAL. Performance Highlights CMP. `363 Target Price - 2QFY2013 Result Update Oil & Gas. Investment Period -

Asian Pay Television Trust (LHS)

Swire Properties (LHS)

Buy (Maintained) Above Expectations. Technology - Software & Services Target Price: SGD1.00 Market Cap: USD1,540m Price: SGD0.86

Chow Tai Fook (1929 HK)

Telecommunications. Thailand Industry Focus. JAS s non-entry already priced in. DBS Group Research. Equity 14 Mar 2016 SET : 1,393.

Kalbe Farma(KLBF IJ) BUY(Unchanged) Not a Fruitful Year. Equity Indonesia Consumer. Results Note. 29 February 2016

Cement, Metals & Mining

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

Colgate-Palmolive. Q3FY17 Result Update Steep decline in Sales; EBITDA margin contraction continues. Sector: FMCG CMP: ` 879. Recommendation: HOLD

CMP* (Rs) 203 Upside/ (Downside) (%) 23. Market Cap. (Rs bn) 116 Free Float (%) 61 Shares O/S (mn) 572

Quarterly results (YE Mar) 4QFY13 4QFY14 YoY(%) FY13 FY14 YoY(%)

Wika Beton (WTON IJ) BUY (Unchanged) Equity Indonesia Construction. In-line result with increased capacity. Results Note.

Flash Note. Singapore. Frasers Centrepoint Ltd (FCL SP) : BUY. Heaven in the City of Angels. DBS Group Research. Equity 4 Apr 2017

Institutional Equities

Wijaya Karya (WIKA IJ)

Colgate-Palmolive. Q2FY18 Result Update Volume pressure continues; Soft A&P aids Margin. Sector: FMCG CMP: ` 1,063. Recommendation: HOLD

Colgate-Palmolive. Q1FY18 Result Update Volume pressure continues; Soft A&P aids Margin. Sector: FMCG CMP: ` 1,083. Recommendation: HOLD

HOLD. Coal India Ltd Coal RETAIL EQUITY RESEARCH. Uncertainty remains. GEOJIT BNP PARIBAS Research

Total Access Communication

The Erawan Group. Thailand Company Guide

Marico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015

Medco Energy (MEDC IJ)

Economics Hong Kong chart book HKD rates are sensitive to rising USD rates

Near-term pressure, but long-term outlook positive

CCL Products BUY. Brewing Steadily. CMP Target Price `300 `360. Initiating Coverage Coffee. January 4, year price chart

A nitrile glove price war looming ahead

Nestlé India. Q2CY17 Result Update. Positives priced in; Downgrade to Hold. Sector: FMCG CMP: ` 6,786. Recommendation: HOLD

Luk Fook (590 HK) Hold (downgraded) Target price: HK$ HFY18 results beat, but downgrade from Accumulate to Hold on rich valuation

Waskita Karya (WSKT IJ)

Overseas Education (LHS)

ICICI BANK Ltd. BUY CMP (Rs.) 334 Target (Rs.) 382 Potential Upside 15% Tide set to turn favourably... For private circulation only

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

CMP* (Rs) 263 Upside/ (Downside) (%) 7.3. Market Cap. (Rs bn) 635 Free Float (%) 59 Shares O/S (mn) 2,417

DRB-HICOM. Result Snapshot. Stronger auto earnings. Malaysia Equity Research 29 Aug Refer to important disclosures at the end of this report

Maruti Suzuki India Ltd.

Asian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics

Rallis India SELL. Performance Highlights. `231 Target Price 189 CMP. 2QFY2018 Result Update Agrichemical. Investment Period 12 months

Equity Research

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

Market Access. Results Review 1Q FY17. M&A Securities. Hartalega Holdings Berhad. Record Sales with Lower Margins BUY (TP:RM4.

Indonesia Flash Note. Indofood CBP Sukses Makmur (ICBP IJ) : BUY. Net profit masked by one-off losses. DBS Group Research. Equity 21 Mar 2018

China Gas Utilities Sector

EAST ASIA SECURITIES COMPANY LIMITED 9/F, 10 Des Voeux Road Central, Hong Kong. Dealing: Research: Facsimile:

Trendlines Group (LHS)

Dollarama Inc. Q4 F2017 Results. A straight-forward beat and other notable business updates HIGHLIGHTS. The NBF Daily Bulletin.

Market Access. M&A Securities. Results Review 1Q15. Malayan Banking Bhd BUY (TP: RM10.70) Stabilizing Period. Results Review

Interlink Communication

Bharat Forge. Result Update. Q4FY13 Result Highlights. Valuation. No Respite in Sight May 29, Institutional Research 1

CMP* (Rs) 336 Upside/ (Downside) (%) 21 Bloomberg Ticker. MOIL IN Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133

Silicon Works (108320)

ITC Ltd. BUY CMP (Rs.) 304 Target (Rs.) 336 Potential Upside(%) 11% Valuation: Investment Rationale. For private circulation only

NIIT Technologies. NEUTRAL Higher capex weighing on FCF RESULTS REVIEW 2QFY15 16 OCT 2014

Dalmia Bharat Enterprises

Singapore Company Focus F & N

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E.

Padaeng Industry - PDI

Fineotex Chemical Ltd

Evergreen Fibreboard

Titan Company BUY. Back to Value Zone Validate Rating Upgrade. Institutional Equity Research. November 05, Target Price Rs428.

Larsen & Toubro Ltd.

Market Access. Results Review (1Q16) M&A Securities. Tan Chong Motor Holdings Bhd. Lacking the X-Factor SELL (TP: RM1.

Thailand Banks. Thailand Industry Focus. FY16 results turned out stronger than expected. DBS Group Research. Equity 23 Jan 2017 SET : 1,562.

FX Viewpoint. Tuesday, January 10, Asia Net portfolio capital inflow update

Key estimate revision. Financial summary. Year FY16E 29, % 3,583 2, FY17E 26, % 3,478 2,

Ramco Cement. Rating: Target price: EPS: Rating CMP. Target BUY. Rs.415. Rs. 360

Far East Horizon (LHS)

Asian Paints. CMP: INR2,722 TP: INR3,161 Buy

Company Overview. Financial Performance

Company Overview. Industry Overview. Financial Performance

Company Overview. Financial Performance

Healty cigarette-driven growth

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

BURSA MALAYSIA BUY. Riding on sustained trading interest. Company report. (Maintained) Rationale for report: Company Result STOCK EXCHANGE

Emkay. Demand environment remain weak. Century Plyboards. Result highlights. Slowdown in plywood segment impacted revenue growth

Bumrungrad Hospital. Thailand Company Guide

Sunway Berhad. OUTPERFORM Price: RM2.65 Target Price: RM3.08 KENANGA RESEARCH. Within expectations. Results Note KENANGA RESEARCH.

China Lilang (1234 HK)

Transcription:

Thailand DBS Group Research. Equity FV Bt3.04 SET: 694.09 (Downgrade from Buy) Price Target : 1-year Bt3.00 (prev. Bt5.82) Reason for Report : Company visit ANALYST Vichitr Kuladejkhuna, CFA 66 (0) 2657 7826 vichitrk@th.dbsvickers.com FORECASTS AND VALUATION FY Mar (Btm) 2004A 2005A 2006A 2007F Turnover 3,263 3,300 4,322 4,581 EBITDA 856 745 623 955 Net Profit 721 561 343 625 Normalized Profit 704 528 331 625 EPS (Bt) 0.90 0.70 0.43 0.78 EPS Gth (%) 45.4 (22.2) (38.8) 0.8 P/E (x) 3.4 4.3 7.1 3.9 EV/EBITDA (x) 2.3 4.7 4.7 2.6 DPS(Bt) 0.35 0.28 0.17 0.31 Div Yield (%) 11.5 9.2 5.6 10.3 ROE (%) 34.7 16.8 9.7 16.3 Net Gearing (%) cash 31.3 13.1 0.7 Book Value (Bt) 4.03 4.34 4.50 5.09 P/Book Value (x) 0.8 0.7 0.7 0.6 SHARE PRICE CHART Bt 6.50 5.50 4.50 3.50 100-Day MA 2.50 Aug-05 Oct-05 Dec-05 Feb-06 Apr-06 Jun-06 Aug-06 AT A GLANCE Issued Capital (m shrs) 800 Market Capital (Btm/US$m) 2,432/ 64 Major Shareholders (%) Polyplex (Asia) Pte. Ltd. 53.5 Polyplex Corp. Ltd. 16.5 Free Float (%) 30.0 Avg Daily Volume ('000 shrs) 2,029 Earnings Rev : FY07: -49% Consenus EPS: FY06: Bt1.02 ; FY07:Bt0.95 Variance vs Cons: FY06: -57.9% ; FY07: -17.7% Sector: Packaging Bloomberg/Reuters Code: PTL TB / PTL.BK Principal Business : Manufactures BOPET film for the packaging industry. 3 August 2006 Weak prospects! PTL reported disappointing 1QFY07 net profit (ending Jun 2006) of Bt31m, tumbling 84% y-o-y and 58% q-o-q. Despite 49% y-o-y higher sales volume led by its new Turkey plant, the sharp drop reflected the severe contraction in product margins.! Prospects for subsequent quarters weak. The current oversupply of PET film could limit price hikes, while PTA (major raw material) price should increase as PX (paraxylene, raw material for PTA) spot price has reached a record high of US$1,400/ton in late Jul 2006. As a result, we expect earnings to remain weak at least until end 2006.! Downgrade to Fully Valued. Following weak 4QFY06 (ending Mar 2006) results, we expected margins had bottomed out and FY07 earnings to be supported by additional sales volume from the new Turkey plant. However, 1QFY07 net profit only accounted for 5% of our previous FY07 forecast. Hence, to reflect the anticipated strong rise in raw material prices, particularly in 2QFY07 (ending Sep 2006), we cut our FY07 net profit forecast by 49% to Bt343m (EPS: Bt0.43), and subsequently downgraded our target price to Bt3.00, based on 7x 2007 PE. We also downgrade our recommendation to Fully Valued, and recommend to switch to ATC (Buy, TP: Bt33) as ATC is a beneficiary of strong aromatics prices. PET film oversupply may last throughout 2006. Global utilization rate of PET film (thin & thick film; thin film accounts for c.80%) started to tumble in 2004 to 82% from 88% in 2003 due to large capacity addition, mostly in Asia. Utilization fell further in 2005 to 75% with more additional supply. This was reflected in PTL s gross margin, which averaged 29.8% in FY05, and narrowed to 26.8% in FY06. The most notable drop was in 4QFY06, when gross margin dropped to 18.2% from 28.3% in 3Q06, which we thought had bottomed out. However, margin continued to drop further to 14.5% in 1QFY07 due mainly to rising raw material costs. In our discussion with PTL management, the company expects the oversupply situation to improve in 2007. But in the current market environment, we foresee limited opportunity for PET film producers to raise selling prices to fully capture the rising raw material costs. Unexpected rise in raw material prices. PTL s raw materials for producing PET film are PTA and MEG; PTA s raw material is paraxylene (PX). PX price has been strong since Jan-Mar 2006, which resulted in high PTA price that hit PTL s margins in 4QFY06. The continued rise in crude oil prices during Apr-Jun 2006 led to higher raw material costs. Together with rising electricity tariff and higher diesel cost, PTL s gross margin dropped further to 14.5%. PX price continued to rise to a record high in July on the back of rising crude oil prices and news of project delays relating to new PX supply in the Middle East. High crude oil prices, resilient PX demand, and delays in new supply should continue to support strong PX price in the near term, until the end of 2006. www.dbsvickers.com Refer to important disclosures at the end of this report

What could trigger margin rebound? (i) Product prices: current selling prices are limited by oversupply. If product margins remain narrow, high-cost producers will be forced to reduce capacity or shut down. This should ease competition and allow the remaining producers to pass on higher costs to customers by gradually raising product prices. (ii) Costs: A sharp drop in crude oil prices should help to lower power and fuel expenses, and potentially lower raw material costs. However, we expect crude oil prices to remain at the current high levels until the end of 2006. In the short term, even if crude oil prices drop, we expect PX prices to remain strong, supported by resilient demand, and expected tight supply as a result of new supply delays in the Middle East. This would in turn sustain raw material price for PTL. Healthy balance sheet. As at 31 Jun 2006, PTL s net gearing was 41%, while Interest Coverage Ratio (EBITDA/Interest expense) was 4.4x for the quarter. We estimate that PTL s gross margin would have to drop to 8% (which is only remotely possible; FY04-06 average: 28.3%, 4Q06: 18.2%, 1Q07: 14.5%), before the company starts to face difficulty in servicing its debt. Generally, PTL s financial status is healthy. New volume from Turkey plant insufficient to offset falling margins. The new thin film plant in Turkey started operation in Dec 2005. Utilisation was ramped up to 75% and 90% in 4QFY06 and 1QFY07, respectively. The Metallizer machine was commissioned in Mar 2006, and has started production. Despite the 49% y-o-y increase in sales volume in 1Q07, sales revenue only grew 38% y-oy, implying 6% y-o-y drop in the average selling price. On the other hand, aggregate COGS and SG&A rose 74% y-o-y, which caused operating profit to drop 83% y-o-y. Expansion projects. PTL s current ongoing expansion projects include: (i) 45,500 t.p.a. PET resin (Turkey) capacity, expected to be completed by end 2006 and improve product margins; (ii) Extrusion Coating/Lamination project (Thailand) - PTL plans to install 2 separate extrusion coating lines in 2 phases with combined capacity of 150-200m sqm. Investment cost is estimated at US$5m per line. The first line should be completed in the next 6-12 months. The project should help PTL to diversify into more value added products. PTL indicated earlier that it was considering getting into thick film production with a production capacity of 20,000 t.p.a. at an estimated investment cost of US$40m. The project is currently suspended due to unfavorable market conditions. 2 of 5

Quarterly Results Summary FY Mar (Btm) 1Q06 2Q06 3Q06 4Q06 1Q07 % chg % chg Ending 30-Jun-06 30-Sep-06 31-Dec-05 31-Mar-06 30-Jun-07 y-o-y q-o-q Total sales 751 743 742 1,063 1,038 38% -2% Cost of sales (511) (503) (532) (870) (888) 74% 2% Gross profit 240 240 210 193 150-38% -22% SGA (85) (77) (109) (150) (124) 47% -17% Optg profit 156 163 101 43 26-83% -40% Other income 25 22 15 31 19-25% -40% FX gain (loss) 13 (4) 20 4 12-2% 197% EBIT 193 182 137 78 57-71% -27% Interest expenses (0) (3) (21) (1) (21) 4455% 1868% Profit before tax 193 179 115 77 36-81% -53% Income tax - - - (5) (4) n.m. -21% Profit before minority interest 193 179 115 72 32-83% -55% Minority interest - - - 1 (2) n.m. -216% Net income 193 179 115 74 31-84% -58% Normalized profit 180 183 95 70 20-89% -71% Shares (m) 800 800 800 800 800 0% 0% Eps (Bt) 0.24 0.22 0.14 0.09 0.04-84% -58% Norm. EPS (Bt) 0.23 0.23 0.12 0.09 0.02-89% -71% EBITDA 224 214 176 131 107-52% -18% Gross Margin 32% 32% 28% 18% 14% SGA/Sales 11% 10% 15% 14% 12% Operating Margin 21% 22% 14% 4% 2% EBITDA margin 30% 29% 24% 12% 10% Net Margin 26% 24% 16% 7% 3% Source; Company, DBS Vickers 3 of 5

Summary Earnings Model (FY05-08) FY Mar (Btm) 2005A 2006A 2007F 2008F Total sales 3,263 3,300 4,322 4,581 Cost of sales (2,289) (2,416) (3,489) (3,482) Gross profit 974 884 832 1,100 SGA (319) (421) (502) (527) Optg profit 655 463 331 573 Other income 92 127 92 96 EBIT 747 590 423 669 Interest expenses (26) (26) (74) (43) Profit before tax 721 565 349 625 Income tax - (5) (4) - Profit before minority interest 721 560 345 625 Minority interest - 1 (2) - Net income 721 561 343 625 Normalized profit 704 528 331 625 Shares (m) 800 801 802 803 EPS (Bt) 0.90 0.70 0.43 0.78 Norm. EPS (Bt) 0.88 0.66 0.41 0.78 EBITDA 856 745 623 955 Gross Margin 30% 27% 19% 24% SGA/Sales 10% 13% 12% 12% Operating Margin 20% 14% 8% 13% EBITDA margin 26% 23% 14% 21% Net Margin 22% 17% 8% 14% Source; Company, DBS Vickers 4 of 5

ANALYST CERTIFICATION The research analyst primarily responsible for the content of this research report, in part or in whole certifies that the views about the companies and their securities expressed in this report accurately reflect his/her personal views. The analyst also certifies that no part of his/her compensation was, is, or will be, directly, or indirectly, related to specific recommendations or views expressed in this report. This document is published by DBS Vickers Securities (Thailand) Co., Ltd. ("DBSVT"), a direct wholly-owned subsidiary of DBS Vickers Securities Holding Pte Ltd. The research is based on information obtained from sources believed to be reliable, but we do not make any representation or warranty as to its accuracy, completeness or correctness. Opinions expressed are subject to change without notice. This document is prepared for general circulation. Any recommendation contained in this document does not have regard to the specific investment objectives, financial situation and the particular needs of any specific addressee. This document is for the information of addressees only and is not to be taken in substitution for the exercise of judgement by addressees, who should obtain separate legal or financial advice. DBSVT accepts no liability whatsoever for any direct or consequential loss arising from any use of this document or further communication given in relation to this document. This document is not to be construed as an offer or a solicitation of an offer to buy or sell any securities. DBS Vickers Securities Holdings Pte Ltd is a wholly-owned subsidiary of DBS Bank Ltd. DBS Bank Ltd along with its affiliates and/or persons associated with any of them may from time to time have interests in the securities mentioned in this document. DBSVT, DBS Vickers Securities (Singapore) Pte Ltd ( DBSVS ). DBS Bank Ltd and their associates, their directors, and/or employees may have positions in, and may effect transactions in securities mentioned herein and may also perform or seek to perform broking, investment banking and other banking services for these companies. DBSVT, DBSVS, DBS Bank Ltd and/or other affiliates of DBS Vickers Securities (USA) Inc ("DBSVUSA"), a U.S.-registered brokerdealer, may beneficially own a total of 1% or more of any class of common equity securities of the subject company mentioned in this document. DBSVT, DBSVS, DBS Bank Ltd and/or other affiliates of DBSVUSA may, within the past 12 months, have received compensation and/or within the next 3 months seek to obtain compensation for investment banking services from the subject company. DBSVUSA does not have its own investment banking or research department, nor has it participated in any investment banking transaction as a manager or co-manager in the past twelve months. Any US persons wishing to obtain further information, including any clarification on disclosures in this disclaimer, or to effect a transaction in any security discussed in this document should contact DBSVUSA exclusively. DBS Vickers Securities (UK) Ltd is an authorised person in the meaning of the Financial Services and Markets Act and is regulated by The Financial Services Authority. Research distributed in the UK is intended only for institutional clients. DBS Vickers Securities (Thailand) 989 Siam Tower, 9 th,14 th 15 th Rama1 Road, Pathumwan, Bangkok Thailand 10330 Tel. 66 (0) 2657 7831, Fax: 66 (0) 2658 1269 Floor, 5 of 5